MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares
MLTX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
MLTX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
MLTX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 7 31,8%
- Achat 10 45,5%
- Conserver 3 13,6%
- Vente 1 4,5%
- Vente forte 1 4,5%
Objectif de cours à 12 mois
13 analystes · 2026-08-16Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.98 | $-0.91 | -0.07% |
| 31 décembre 2025 | $-0.92 | $-1.01 | 0.09% |
| 30 septembre 2025 | $-1.10 | $-0.90 | -0.20% |
| 30 juin 2025 | $-0.87 | $-0.74 | -0.13% |
| 31 mars 2025 | $-0.63 | $-0.77 | 0.14% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| MLTX | — | -3.7 | — | — | -60.5% | — |
| CRSP | $5.03B | -8.1 | -90.6% | -16569.8% | -32.0% | — |
| ACIU | — | — | — | — | — | — |
| ADCT | $444M | -3.2 | 14.8% | -175.3% | 74.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $203M | $113M | $32M | $42M | · | |
| SG&A Expense | $42M | $30M | $22M | $23M | $5M | |
| Operating Expenses | $245M | $143M | $54M | $65M | · | |
| Operating Income | $-245M | $-143M | $-54M | $-65M | $-5M | |
| Interest Income | · | · | · | · | $27.7K | |
| Other Non-op | · | · | · | $591.7K | $27.7K | |
| Pretax Income | $-230M | $-121M | $-44M | $-64M | · | |
| Income Tax | $611.0K | $282.0K | $94.0K | $36.4K | · | |
| Net Income | $-227M | $-119M | $-36M | $-50M | $-5M | |
| EPS (Basic) | $-3.53 | $-1.89 | $-0.73 | $-1.70 | · | |
| EPS (Diluted) | $-3.53 | $-1.89 | $-0.73 | $-1.70 | · | |
| Shares (Basic) | 64,463,889 | 62,870,237 | 49,122,534 | 29,361,353 | · | |
| Shares (Diluted) | 64,463,889 | 62,870,237 | 49,122,534 | 29,361,353 | 360,000,000 | |
| EBITDA | $-242M | $-142M | · | $-65M | $-5M |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $335M | $180M | $451M | $40M | $8M | |
| Prepaid Expense | $23M | $23M | $2M | $4M | $1M | |
| Current Assets | $422M | $474M | $514M | $77M | $10M | |
| PP&E (Net) | $577.0K | $722.0K | $320.9K | $49.4K | $45.7K | |
| Other Non-current Assets | $596.0K | $0 | · | · | · | |
| Total Assets | $424M | $478M | $527M | $77M | $10M | |
| Accrued Liabilities | · | · | · | · | $4M | |
| Short-term Debt | · | · | · | $0 | $15M | |
| Current Liabilities | $45M | $22M | $10M | $8M | $21M | |
| Capital Leases | $374.0K | $1M | $2M | $129.0K | $0 | |
| Total Liabilities | $120M | $25M | $13M | $8M | $21M | |
| Long-term Debt | $74M | $0 | · | · | · | |
| Total Debt | · | · | · | $0 | · | |
| Common Stock | · | · | · | $0 | $38.5K | |
| Paid-in Capital | $767M | $677M | $610M | $129M | $42M | |
| Retained Earnings | $-463M | $-236M | $-117M | $-81M | $-54M | |
| Treasury Stock | · | · | · | $0 | $6.2K | |
| AOCI | $604.0K | $5M | $2M | $350.9K | $-168.2K | |
| Stockholders' Equity | $304M | $447M | $496M | $49M | $-12M | |
| Liabilities + Equity | $424M | $478M | $527M | $77M | $10M | |
| Shares Outstanding | · | · | · | · | 12,161,331 |
Flux de trésorerie 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $3M | $1M | $370.0K | $164.8K | · | |
| Stock-based Comp | $13M | $7M | $7M | $10M | · | |
| Other Non-cash | $16M | $-6M | · | · | · | |
| Operating Cash Flow | $-196M | $-117M | $-43M | $-56M | $-611.1K | |
| CapEx | $35.0K | $520.0K | $284.0K | $16.0K | · | |
| Investing Cash Flow | $203M | $-206M | $-25M | $-32M | · | |
| Debt Issued | $73M | $0 | $0 | · | · | |
| Net Debt Issued | $73M | · | · | · | · | |
| Stock Repurchased | · | $50 | $0 | $0 | · | |
| Net Stock Activity | · | $-50 | · | · | · | |
| Financing Cash Flow | $146M | $51M | $480M | $120M | $-58.1K | |
| Net Change in Cash | $154M | $-271M | $412M | $31M | $-669.1K | |
| Taxes Paid | $799.0K | $147.0K | $42.0K | $4.3K | · | |
| Free Cash Flow | $-196M | $-117M | · | $-56M | · |
Rentabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -50.4% | -23.7% | · | -115.5% | -3.9% | |
| ROE | -60.5% | -25.2% | · | -268.3% | 94.1% | |
| ROIC | -80.6% | -32.1% | · | -133.1% | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 21.1 | · | 10.0 | 0.2 | |
| Quick Ratio | 7.4 | 8.0 | · | 5.2 | 0.2 | |
| Debt / Equity | · | · | · | 0.0 | · |
Valorisation (TTM) 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-227M | $-119M | $-36M | $-50M | $-5M | |
| P/E | -3.7 | -28.7 | -82.7 | -6.2 | · | |
| Earnings Yield | -26.8% | -3.5% | -1.2% | -16.2% | · |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $50M | $55M | $56M | $61M | $50M | $36M | $40M | $36M | $24M | $13M | $8M | $9M | $7M | $9M | $11M | $10M | |
| SG&A Expense | $11M | $16M | $9M | $11M | $11M | $11M | $9M | $7M | $7M | $7M | $5M | $4M | $6M | $6M | $6M | $5M | |
| Operating Expenses | $62M | $70M | $65M | $71M | $61M | $47M | $50M | $43M | $31M | $20M | $13M | $13M | $13M | $15M | $18M | $16M | |
| Operating Income | $-62M | $-70M | $-65M | $-71M | $-61M | $-47M | $-50M | $-43M | $-31M | $-20M | $-13M | $-13M | $-13M | $-15M | $-18M | $-16M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $657 | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $8.4K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $842.7K | $723.6K | $37.6K | $245.1K | $69.5K | |
| Income Tax | $90.0K | $622.0K | $248.0K | $115.0K | $95.0K | $153.0K | $41.0K | $92.0K | $79.0K | $70.0K | $28.9K | $10.1K | $11.0K | $8.7K | $9.3K | $7.3K | |
| Net Income | $-62M | $-70M | $-62M | $-70M | $-55M | $-40M | $-46M | $-35M | $-24M | $-14M | $-9M | $-10M | $-9M | $-10M | $-12M | $-16M | |
| EPS (Basic) | $-0.84 | $-0.98 | $-0.93 | $-1.10 | $-0.87 | $-0.63 | $-0.72 | $-0.56 | $-0.39 | $-0.22 | $-0.18 | $-0.23 | $-0.23 | $-0.27 | $-0.34 | $-3.17 | |
| EPS (Diluted) | $-0.84 | $-0.98 | $-0.93 | $-1.10 | $-0.87 | $-0.63 | $-0.72 | $-0.56 | $-0.39 | $-0.22 | $-0.18 | $-0.23 | $-0.23 | $-0.27 | $-0.34 | $-3.17 | |
| Shares (Basic) | 73,915,296 | 71,273,650 | -125,422,611 | 63,369,984 | 63,282,728 | 63,233,788 | -125,538,394 | 62,896,782 | 62,874,637 | 62,637,212 | 53,517,655 | 43,718,464 | 39,061,977 | 36,925,639 | 35,201,713 | 5,013,646 | |
| Shares (Diluted) | 73,915,296 | 71,273,650 | -125,422,611 | 63,369,984 | 63,282,728 | 63,233,788 | -125,538,394 | 62,896,782 | 62,874,637 | 62,637,212 | 53,517,655 | 43,718,464 | 39,061,977 | 36,925,639 | 35,201,713 | 5,013,646 | |
| EBITDA | $-62M | $-69M | · | $-71M | $-61M | $-47M | · | $-43M | $-31M | $-20M | $-13M | $-13M | $-13M | $-15M | $-18M | $-3M |
Bilan 21
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $478M | $298M | $335M | $351M | $307M | $272M | $180M | $376M | $343M | $458M | $318M | $502M | $50M | $41M | $93M | $23.3K | |
| Prepaid Expense | $26M | $33M | $23M | $27M | $27M | $23M | $23M | $16M | $15M | $5M | $3M | $4M | $3M | $4M | $5M | $135.9K | |
| Current Assets | $570M | $397M | $422M | $411M | $455M | $506M | $474M | $512M | $537M | $554M | $500M | $506M | $67M | $89M | $98M | $116M | |
| PP&E (Net) | $487.0K | $532.0K | $577.0K | $622.0K | $667.0K | $711.0K | $722.0K | $581.4K | $481.7K | $509.8K | $39.5K | $42.8K | $46.1K | $52.7K | $56.0K | · | |
| Other Non-current Assets | $1M | $1M | $596.0K | $587.0K | $2M | $2M | $0 | · | · | · | · | · | · | · | · | · | |
| Total Assets | $574M | $400M | $424M | $414M | $460M | $511M | $478M | $518M | $545M | $564M | $500M | $507M | $67M | $89M | $98M | $231M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $150.0K | |
| Current Liabilities | $45M | $46M | $45M | $48M | $27M | $24M | $22M | $20M | $12M | $9M | $10M | $7M | $7M | $6M | $4M | $203M | |
| Capital Leases | $772.0K | $865.0K | $374.0K | $486.0K | $836.0K | $1M | $1M | $2M | $2M | $2M | $13.1K | $53.0K | $91.1K | · | · | · | |
| Total Liabilities | $146M | $146M | $120M | $123M | $102M | $99M | $25M | $23M | $15M | $12M | $11M | $8M | $8M | $6M | $4M | $207M | |
| Long-term Debt | $100M | $99M | $74M | $74M | $73M | $73M | $0 | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $150.0K | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $385 | |
| Paid-in Capital | $1.02B | $786M | $767M | $689M | $684M | $681M | $677M | $675M | $672M | $670M | $531M | $590M | $131M | $124M | $122M | $34M | |
| Retained Earnings | $-594M | $-533M | $-463M | $-400M | $-331M | $-276M | $-236M | $-190M | $-155M | $-130M | $-109M | $-100M | $-90M | $-69M | $-59M | $-10M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | |
| AOCI | $630.0K | $322.0K | $604.0K | $278.0K | $520.0K | $2M | $5M | $3M | $3M | $3M | $3M | $35.1K | $340.1K | $245.3K | $133.7K | · | |
| Stockholders' Equity | $428M | $254M | $304M | $289M | $354M | $408M | $447M | $488M | $521M | $543M | $425M | $490M | $42M | $55M | $64M | $24M | |
| Liabilities + Equity | $574M | $400M | $424M | $414M | $460M | $511M | $478M | $518M | $545M | $564M | $500M | $507M | $67M | $89M | $98M | $231M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | 0 | 0 | · |
Flux de trésorerie 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $896.0K | $845.0K | $751.0K | $745.0K | $742.0K | $378.0K | $364.0K | $351.0K | $342.0K | $328.0K | · | · | · | · | · | · | |
| Stock-based Comp | $3M | $13M | $4M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $3M | $3M | $2M | $2M | |
| Other Non-cash | · | $-11M | · | · | · | $-864.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-56M | $-66M | $-59M | $-45M | $-55M | $-38M | $-48M | $-25M | $-28M | $-15M | $-9M | $-12M | $-9M | $-9M | $-34M | $-14M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $35.0K | $176.0K | $132.2K | $235 | $212.0K | $0 | $0 | $0 | $0 | $-2 | $16.0K | |
| Investing Cash Flow | $322.0K | $98.0K | $-30M | $88M | $88M | $56M | $-147M | $58M | $-88M | $-29M | $-174M | $13M | $20M | $-42M | $2 | $-16.0K | |
| Debt Issued | $0 | $24M | $0 | $0 | $0 | $73M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Debt Issued | · | $24M | · | · | · | $73M | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $44M | $6M | · | $0 | $0 | $0 | · | $-190 | $-190 | $53M | $0 | $451M | $0 | $0 | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | $0 | $50 | $0 | $0 | $0 | · | · | · | |
| Net Stock Activity | · | $6M | · | · | · | $0 | · | · | · | $53M | · | · | · | · | · | · | |
| Financing Cash Flow | $235M | $31M | $72M | $480.0K | $0 | $73M | $151.0K | $183.1K | $95 | $51M | $0 | $451M | $0 | $0 | $120M | $15M | |
| Net Change in Cash | $179M | $-36M | $-16M | $44M | $35M | $91M | $-195M | $33M | $-116M | $7M | $-184M | $452M | $11M | $-52M | $85M | $795.3K | |
| Taxes Paid | · | · | $733.0K | · | · | · | $143.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-66M | · | · | · | $-38M | · | · | · | $-15M | · | · | $-9M | · | · | · |
Rentabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.9% | -15.3% | · | -14.9% | -11.0% | -7.4% | · | -7.0% | -4.6% | -4.3% | -3.2% | -3.4% | -6.0% | -9.9% | -11.3% | -1.6% | |
| ROE | -15.8% | -21.1% | · | -17.9% | -12.6% | -8.4% | · | -7.8% | -4.8% | -4.7% | -3.9% | -3.7% | -27.1% | -40.1% | -35.4% | -18.4% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | 8.6 | · | 8.5 | 16.6 | 21.1 | · | 25.5 | 43.7 | 62.1 | 48.5 | 71.0 | 9.1 | 14.7 | 25.5 | 0.6 | |
| Quick Ratio | 10.5 | 6.5 | · | 7.3 | 11.2 | 11.3 | · | 18.7 | 27.9 | 51.4 | 30.9 | 70.3 | 6.9 | 6.8 | 24.0 | 0.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -4127.1 |
Valorisation (TTM) 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-256M | $-235M | · | $-200M | $-155M | $-113M | · | $-83M | $-58M | $-42M | $-39M | $-41M | $-47M | $-44M | $-67M | $-55M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $-41M | $-93M | · | |
| P/E | -5.1 | -5.2 | · | -2.3 | -19.3 | -21.7 | · | -37.3 | -43.1 | -58.4 | -62.6 | -47.7 | -5.3 | -1.2 | -0.6 | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.8 | 5.3 | · | |
| Earnings Yield | -19.5% | -19.2% | · | -44.1% | -5.2% | -4.6% | · | -2.7% | -2.3% | -1.7% | -1.6% | -2.1% | -18.8% | -82.6% | -172.2% | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-227M | $-119M | $-36M | $-50M | $-5M |
| BPA dilué | $-3.53 | $-1.89 | $-0.73 | $-1.70 | — |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | — | — | — | 0.0 | — |
| Ratio de liquidité | 9.3 | 21.1 | — | 10.0 | 0.2 |
| Ratio de liquidité réduite | 7.4 | 8.0 | — | 5.2 | 0.2 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-196M | $-117M | — | $-56M | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 197 déclarants · $1.2B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 48 (+6 vs T. préc.) | 13 (-8 vs T. préc.) | 68 (+20 vs T. préc.) | 49 (+4 vs T. préc.) | +10.7M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BVF INC/IL | $311 544 999 | 16 001 284 | 25,58% | Actions |
| Deep Track Capital, LP | $136 271 017 | 6 999 025 | 11,19% | Actions |
| D. E. Shaw & Co., Inc. | $65 526 421 | 3 365 507 | 5,38% | Actions |
| Cormorant Asset Management, LP | $62 409 781 | 3 205 433 | 5,12% | Actions |
| Logos Global Management LP | $52 082 250 | 2 675 000 | 4,28% | Actions |
| Weiss Asset Management LP | $50 267 899 | 2 581 813 | 4,13% | Actions |
| CITADEL ADVISORS LLC | $38 412 227 | 1 972 893 | 3,15% | Actions |
| TWO SIGMA INVESTMENTS, LP | $33 397 845 | 1 715 349 | 2,74% | Actions |
| MPM BIOIMPACT LLC | $31 287 647 | 1 606 967 | 2,57% | Actions |
| Nuveen Asset Management, LLC | $30 790 611 | 568 617 | 2,53% | Actions |
| Vivo Capital, LLC | $27 258 000 | 1 400 000 | 2,24% | Actions |
| Point72 Asset Management, L.P. | $22 560 512 | 1 158 732 | 1,85% | Actions |
| Balyasny Asset Management L.P. | $17 770 561 | 912 715 | 1,46% | Actions |
| GREAT POINT PARTNERS LLC | $16 662 679 | 855 813 | 1,37% | Actions |
| Candriam S.C.A. | $14 972 924 | 769 766 | 1,23% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $14 617 628 | 750 777 | 1,20% | Actions |
| Trails Edge Capital Partners, LP | $14 602 500 | 750 000 | 1,20% | Actions |
| BANK OF AMERICA CORP /DE/ | $13 779 250 | 707 717 | 1,13% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $12 524 428 | 643 268 | 1,03% | Actions |
| MILLENNIUM MANAGEMENT LLC | $12 386 561 | 636 187 | 1,02% | Actions |
| Qube Research & Technologies Ltd | $9 661 832 | 496 242 | 0,79% | Actions |
| JANE STREET GROUP, LLC | $8 824 661 | 453 244 | 0,72% | Actions |
| ALGERT GLOBAL LLC | $7 534 111 | 386 960 | 0,62% | Actions |
| Rhenman & Partners Asset Management AB | $7 492 056 | 384 800 | 0,62% | Actions |
| Trexquant Investment LP | $7 358 609 | 377 946 | 0,60% | Actions |
| Capricorn Fund Managers Ltd | $7 294 892 | 374 866 | 0,60% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $6 649 725 | 341 537 | 0,55% | Actions |
| Caption Management, LLC | $6 364 743 | 326 900 | 0,52% | Option d'achat |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 249 870 | 321 000 | 0,51% | Option d'achat |
| Granahan Investment Management, LLC | $6 111 321 | 313 884 | 0,50% | Actions |
| Boxer Capital Management, LLC | $5 354 250 | 275 000 | 0,44% | Actions |
| JANE STREET GROUP, LLC | $5 334 780 | 274 000 | 0,44% | Option d'achat |
| CITADEL ADVISORS LLC | $5 317 257 | 273 100 | 0,44% | Option d'achat |
| Susquehanna Portfolio Strategies, LLC | $4 944 874 | 253 974 | 0,41% | Actions |
| Holocene Advisors, LP | $4 867 500 | 250 000 | 0,40% | Actions |
| Burkehill Global Management, LP | $4 867 500 | 250 000 | 0,40% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 823 537 | 247 742 | 0,40% | Actions |
| Walleye Capital LLC | $4 806 539 | 246 869 | 0,39% | Actions |
| J. Goldman & Co LP | $4 204 449 | 215 945 | 0,35% | Actions |
| Y-Intercept (Hong Kong) Ltd | $4 202 580 | 215 849 | 0,35% | Actions |
| ACUTA CAPITAL PARTNERS, LLC | $4 198 744 | 215 652 | 0,34% | Actions |
| CITADEL ADVISORS LLC | $4 123 746 | 211 800 | 0,34% | Option de vente |
| Verition Fund Management LLC | $4 032 276 | 207 102 | 0,33% | Actions |
| HighVista Strategies LLC | $3 659 308 | 187 946 | 0,30% | Actions |
| RICE HALL JAMES & ASSOCIATES, LLC | $3 578 605 | 183 801 | 0,29% | Actions |
| CONGRESS ASSET MANAGEMENT CO | $3 513 323 | 180 448 | 0,29% | Actions |
| Kalehua Capital Management LLC | $3 421 541 | 175 734 | 0,28% | Actions |
| Voleon Capital Management LP | $3 386 008 | 173 909 | 0,28% | Actions |
| Exome Asset Management LLC | $3 241 619 | 166 493 | 0,27% | Actions |
| Longaeva Partners L.P. | $3 145 515 | 161 557 | 0,26% | Actions |
| XTX Topco Ltd | $2 968 630 | 152 472 | 0,24% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 943 864 | 151 200 | 0,24% | Option de vente |
| FMR LLC | $2 795 074 | 143 558 | 0,23% | Actions |
| BlackRock, Inc. | $2 545 819 | 130 756 | 0,21% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 537 467 | 130 327 | 0,21% | Actions |
| GOLDMAN SACHS GROUP INC | $2 520 080 | 129 434 | 0,21% | Actions |
| Caption Management, LLC | $2 509 683 | 128 900 | 0,21% | Option de vente |
| TD Asset Management Inc | $2 497 495 | 128 274 | 0,21% | Actions |
| Engineers Gate Manager LP | $2 172 657 | 111 590 | 0,18% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2 142 000 | 110 000 | 0,18% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2 133 523 | 109 580 | 0,18% | Actions |
| Quadrature Capital Ltd | $2 126 202 | 109 204 | 0,17% | Actions |
| Polymer Capital Management (HK) LTD | $1 956 015 | 100 463 | 0,16% | Actions |
| Centiva Capital, LP | $1 947 000 | 100 000 | 0,16% | Option d'achat |
| HEIGHTS CAPITAL MANAGEMENT, INC | $1 947 000 | 100 000 | 0,16% | Actions |
| J. Goldman & Co LP | $1 947 000 | 100 000 | 0,16% | Option d'achat |
| Ghisallo Capital Management LLC | $1 947 000 | 100 000 | 0,16% | Actions |
| SummitTX Capital, L.P. | $1 934 753 | 99 371 | 0,16% | Actions |
| Jain Global LLC | $1 929 983 | 99 126 | 0,16% | Actions |
| TWO SIGMA ADVISERS, LP | $1 735 806 | 131 700 | 0,14% | Actions |
| STATE STREET CORP | $1 697 122 | 87 166 | 0,14% | Actions |
| Swiss National Bank | $1 695 837 | 87 100 | 0,14% | Actions |
| Squarepoint Ops LLC | $1 657 812 | 85 147 | 0,14% | Actions |
| Monashee Investment Management LLC | $1 460 250 | 75 000 | 0,12% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 454 836 | 74 760 | 0,12% | Actions |
| Mariner, LLC | $1 418 907 | 72 875 | 0,12% | Actions |
| Lion Point Capital, LP | $1 314 225 | 67 500 | 0,11% | Actions |
| CAPITAL FUND MANAGEMENT S.A. | $1 273 221 | 65 394 | 0,10% | Actions |
| TUDOR INVESTMENT CORP ET AL | $1 143 668 | 58 740 | 0,09% | Actions |
| Headlands Technologies LLC | $1 111 484 | 57 087 | 0,09% | Actions |
| HAP Trading, LLC | $1 015 000 | 40 000 | 0,08% | Option de vente |
| Stonepine Capital Management, LLC | $973 500 | 50 000 | 0,08% | Actions |
| ExodusPoint Capital Management, LP | $908 198 | 46 646 | 0,07% | Actions |
| JANE STREET GROUP, LLC | $819 687 | 42 100 | 0,07% | Option de vente |
| VANGUARD ASSET MANAGEMENT, Ltd | $704 717 | 36 195 | 0,06% | Actions |
| FRED ALGER MANAGEMENT, LLC | $627 985 | 32 254 | 0,05% | Actions |
| Campbell & CO Investment Adviser LLC | $577 831 | 29 678 | 0,05% | Actions |
| Aquatic Capital Management LLC | $547 769 | 28 134 | 0,04% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $546 077 | 29 296 | 0,04% | Actions |
| Quantbot Technologies LP | $541 402 | 27 807 | 0,04% | Actions |
| Schonfeld Strategic Advisors LLC | $536 884 | 27 575 | 0,04% | Actions |
| ADAR1 Capital Management, LLC | $525 690 | 27 000 | 0,04% | Actions |
| FOX RUN MANAGEMENT, L.L.C. | $517 707 | 26 590 | 0,04% | Actions |
| PRELUDE CAPITAL MANAGEMENT, LLC | $506 162 | 25 997 | 0,04% | Actions |
| IEQ CAPITAL, LLC | $483 927 | 24 855 | 0,04% | Actions |
| Optimize Financial Inc | $455 170 | 24 419 | 0,04% | Actions |
| IMC-Chicago, LLC | $448 745 | 23 048 | 0,04% | Actions |
| AXA Investment Managers S.A. | $435 613 | 60 755 | 0,04% | Actions |
| Graham Capital Management, L.P. | $419 481 | 21 545 | 0,03% | Actions |
| Entropy Technologies, LP | $386 032 | 19 827 | 0,03% | Actions |
Initiés de la société 10 initiés · 3 dirigeants · 6 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Da Silva Jorge Santos | Chief Executive Officer | 10 juillet 2026 S | 2 774 893 | 0 | 7 | $-8 730 001 |
| Matthias Bodenstedt | Chief Financial Officer | 22 juin 2026 S | 1 115 435 | 1 | 7 | $-3 099 694 |
| Kristian Reich | Chief Scientific Officer | 27 juillet 2026 S | 2 711 198 | 0 | 10 | $-8 135 616 |
| Andrew John Phillips | Administrateur | 17 juin 2026 A | — | 0 | 0 | $0 |
| Ramnik Xavier | Administrateur | 17 juin 2026 A | — | 0 | 0 | $0 |
| Loy Spike | Administrateur | 17 juin 2026 A | — | 0 | 0 | $0 |
| Catherine Moukheibir | Administrateur | 17 juin 2026 A | 0 | 0 | 0 | $0 |
| Simon Sturge | Administrateur | 5 juin 2025 A | 171 980 | 0 | 0 | $0 |
| Chen Bihua | Détenteur de 10% | 30 juin 2023 P | 4 927 100 | 0 | 0 | $0 |
| Helix Holdings LLC | — | 5 avril 2022 C | 3 215 000 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Loy Spike ×3 dépôts | 29 juin 2026 | 19,70% | Amendement | — | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, SPIKE LOY ×4 dépôts | 8 octobre 2024 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 8 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,88% | 73 934 NS | 31 mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,82% | 18 661 NS | 30 avril 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 82 021 SH | 8 août 2026 | Quotidien |
| NUSC · Nushares ETF Trust | 0,04% | 33 673 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 130 327 SH | 8 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 14 568 NS | 30 avril 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3 105 SH | 8 août 2026 | Quotidien |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 30 712 NS | 31 mai 2026 | N-PORT |